In Vitro Drug Release Behavior, Mechanism and Antimicrobial Activity of Rifampicin Loaded Low Molecular Weight PLGA-PEG-PLGA Triblock Copolymeric Nanospheres
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Current drug delivery - 10(2013), 6 vom: 1. Dez., Seite 722-731 |
| Beteiligte Personen: |
Gajendiran, M. [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
10 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1934877530 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1934877530 | ||
| 003 | DE-627 | ||
| 005 | 20230517054758.0 | ||
| 007 | tu | ||
| 008 | 140120s2013 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw140117_1 |
| 035 | |a (DE-627)OLC1934877530 | ||
| 035 | |a (DE-599)GBVOLC1934877530 | ||
| 035 | |a (KEY)0555023820131200010000600722invitrodrugreleasebehaviormechanismandantimicrobia | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Gajendiran, M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In Vitro Drug Release Behavior, Mechanism and Antimicrobial Activity of Rifampicin Loaded Low Molecular Weight PLGA-PEG-PLGA Triblock Copolymeric Nanospheres |
| 264 | 1 | |c 2013 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Divakar, S. |4 oth | |
| 700 | 1 | |a Raaman, N. |4 oth | |
| 700 | 1 | |a Balasubramanian, S. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug delivery |d Sharjah : Bentham Sc. Publ., 2004 |g 10(2013), 6 vom: 1. Dez., Seite 722-731 |w (DE-627)48396638X |w (DE-600)2185284-4 |w (DE-576)435514725 |x 1567-2018 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2013 |g number:6 |g day:1 |g month:12 |g pages:722-731 |g extent:10 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 10 |j 2013 |e 6 |b 1 |c 12 |h 722-731 |g 10 | ||